HomeRVLPQ • OTCMKTS
add
RVL Pharmaceuticals PLC
Previous close
$0.00
Day range
$0.00 - $0.00
Market cap
63.50 USD
Avg Volume
7.18K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 49.72M | 184.10% |
Operating expense | 83.04M | -7.41% |
Net income | -51.69M | 20.38% |
Net profit margin | -103.96 | 71.97% |
Earnings per share | -0.65 | 36.64% |
EBITDA | -39.60M | 41.01% |
Effective tax rate | 0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.54M | 10.14% |
Total assets | 128.51M | -11.17% |
Total liabilities | 77.42M | 13.95% |
Total equity | 51.09M | — |
Shares outstanding | 99.35M | — |
Price to book | 0.00 | — |
Return on assets | -18.29% | — |
Return on capital | -21.45% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -51.69M | 20.38% |
Cash from operations | -37.81M | 30.92% |
Cash from investing | 126.00K | -99.89% |
Cash from financing | 41.78M | 130.87% |
Net change in cash | 4.10M | 105.57% |
Free cash flow | -12.68M | 42.76% |
About
Website
Employees
125
